Osteopontin Knockdown Suppresses Tumorigenicity of Human Metastatic Breast Carcinoma, MDA-MB-435
- 1 April 2006
- journal article
- research article
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 23 (2), 123-133
- https://doi.org/10.1007/s10585-006-9013-2
Abstract
Elevated expression of osteopontin (OPN), a secreted phosphoglycoprotein, is frequently associated with many transformed cell lines. Various studies suggest that OPN may contribute to tumor progression as well as metastasis in multiple tumor types. High levels of OPN have been reported in patients with metastatic cancers, including breast. We found that the expression of OPN corroborates with the aggressive phenotype of the breast cancer cells i.e. the expression of OPN is acquired as the breast cancer cells become more aggressive. To assess the role(s) of OPN in breast carcinoma, expression of endogenous OPN was knocked down in metastatic MDA-MB-435 human breast carcinoma cells using RNA interference. We targeted multiple regions of the OPN transcript for RNA interference, along with ‘scrambled’ and ‘non-targeting siRNA pool’ controls to distinguish between target-specific and potential off-target effects including interferon-response gene (PeIF2-α) induction. The OPN knockdown by shRNA suppressed tumor take in immunocompromised mice. The ‘silenced’ cells also showed significantly lower invasion and migration in modified Boyden chamber assays and reduced ability to grow in soft agar. Thus, in addition to the widely reported roles of OPN in late stages of tumor progression, these results provide functional evidence that OPN contributes to breast tumor growth as well.Keywords
This publication has 50 references indexed in Scilit:
- Increased Expression of Osteopontin Contributes to the Progression of Prostate CancerCancer Research, 2006
- Post-translationally modified residues of native human osteopontin are located in clusters: identification of 36 phosphorylation and five O-glycosylation sites and their biological implicationsBiochemical Journal, 2005
- Differential Osteopontin Expression in Phenotypically Distinct Subclones of Murine Breast Cancer Cells Mediates Metastatic BehaviorPublished by Elsevier ,2004
- Optimizing RNA interference for application in mammalian cellsBiochemical Journal, 2004
- Lineage Infidelity of MDA-MB-435 CellsCancer Research, 2004
- Soluble osteopontin inhibits apoptosis of adherent endothelial cells deprived of growth factors*Journal of Cellular Biochemistry, 2002
- Antibodies to different peptides in osteopontin reveal complexities in the various secreted formsJournal of Cellular Biochemistry, 2000
- Systematic variation in gene expression patterns in human cancer cell linesNature Genetics, 2000
- Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cellsOncogene, 1999
- Osteopontin antisense deoxyoligonucleotides inhibit bone resorption by mouse osteoclasts in vitroJournal of Periodontal Research, 1997